The lack of significant differences in serum TGF-β, serum IL-17, and serum Mg levels between the genotypes suggests that these biomarkers may not be strongly influenced by the Calpain 10 SNP 19 genotype in diabetic nephropathy patients. The gene discussed is TGFB1; the disease is diabetic kidney disease.